Funding will support the continued clinical advancement of its lead ocular implant candidate, PA5108, for the reduction of ...

Advanced autofluorescence reveals cellular pigment reservoirs with therapeutic potential at the 2025 International Spectralis Symposium – and Beyond.

The rationale for the study under discussion is that the experience level of the operating surgeon is a potential factor ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

This noninvasive imaging tool reveals early brain pathology through the eye, promising faster and more accurate diagnoses as highlighted at the 2025 International SPECTRALIS Symposium – and Beyond.

EssilorLuxottica and MidEuropa recently entered into an agreement that will allow EssilorLuxottica to acquire Optegra, ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Findings presented at the Heidelberg 2025 International Spectralis Symposium — And Beyond suggest detailed structural data could better inform therapeutic targeting and monitoring.

From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer retinal disease, as presented at the 2025 International SPECTRALIS Symposium – ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, as shared at the 2025 International SPECTRALIS Symposium – and Beyond.